These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 3979390

  • 1. Thrombin-induced fibrinopeptide release from a fibrinogen variant (fibrinogen Sydney I) with an Aalpha Arg-16----His substitution.
    Southan C, Lane DA, Bode W, Henschen A.
    Eur J Biochem; 1985 Mar 15; 147(3):593-600. PubMed ID: 3979390
    [Abstract] [Full Text] [Related]

  • 2. Fibrinogen Seattle II: congenital dysfibrinogenemia with an Arg (A alpha 16)----his substitution.
    Ebert RF, Schreiler WE, Bell WR.
    Thromb Res; 1986 Jul 01; 43(1):7-13. PubMed ID: 3726812
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Steady state kinetic parameters for the thrombin-catalyzed conversion of human fibrinogen to fibrin.
    Higgins DL, Lewis SD, Shafer JA.
    J Biol Chem; 1983 Aug 10; 258(15):9276-82. PubMed ID: 6409903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fibrinopeptide A release is necessary for effective B:b interactions in polymerisation of variant fibrinogens with impaired A:a interactions.
    Soya K, Terasawa F, Okumura N.
    Thromb Haemost; 2013 Feb 10; 109(2):221-8. PubMed ID: 23238100
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM, Mullin JL, Lord ST.
    Biochemistry; 1998 Sep 29; 37(39):13704-9. PubMed ID: 9753458
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization.
    Ruf W, Bender A, Lane DA, Preissner KT, Selmayr E, Müller-Berghaus G.
    Biochim Biophys Acta; 1988 May 12; 965(2-3):169-75. PubMed ID: 3365451
    [Abstract] [Full Text] [Related]

  • 10. Recombinant fibrinogen studies reveal that thrombin specificity dictates order of fibrinopeptide release.
    Mullin JL, Gorkun OV, Binnie CG, Lord ST.
    J Biol Chem; 2000 Aug 18; 275(33):25239-46. PubMed ID: 10837485
    [Abstract] [Full Text] [Related]

  • 11. Fibrinogen Ledyard (A alpha Arg16----Cys): biochemical and physiologic characterization.
    Lee MH, Kaczmarek E, Chin DT, Oda A, McIntosh S, Bauer KA, Clyne LP, McDonagh J.
    Blood; 1991 Oct 01; 78(7):1744-52. PubMed ID: 1912564
    [Abstract] [Full Text] [Related]

  • 12. Fibrinogen Barcelona II: a new case of A alpha 16 Arg----His substitution.
    Borrell M, Vila L, Solá J, Coll I, Fontcuberta J.
    Haemostasis; 1990 Oct 01; 20(1):1-7. PubMed ID: 2323678
    [Abstract] [Full Text] [Related]

  • 13. Kinetics of fibrinopeptide release by thrombin as a function of CaCl2 concentration: different susceptibility of FPA and FPB and evidence for a fibrinogen isoform-specific effect at physiological Ca2+ concentration.
    Profumo A, Turci M, Damonte G, Ferri F, Magatti D, Cardinali B, Cuniberti C, Rocco M.
    Biochemistry; 2003 Oct 28; 42(42):12335-48. PubMed ID: 14567695
    [Abstract] [Full Text] [Related]

  • 14. Fibrinogen Manchester: identification of an abnormal fibrinopeptide A with a C-terminal arginine leads to histidine substitution.
    Southan C, Kehl M, Henschen A, Lane DA.
    Br J Haematol; 1983 May 28; 54(1):143-51. PubMed ID: 6849832
    [Abstract] [Full Text] [Related]

  • 15. Fibrinogen Sapporo: dysfibrinogenemia characterized by the replacement of A alpha arginine-16 by histidine resulting in the delayed release of fibrinopeptide A by thrombin.
    Asakura S, Terukina S, Yamazumi K, Matsuda M, Murayama H, Higuchi A, Musashi M, Sakurada K, Miyazaki T.
    Nihon Ketsueki Gakkai Zasshi; 1989 Sep 28; 52(6):1094-104. PubMed ID: 2588959
    [Abstract] [Full Text] [Related]

  • 16. Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach.
    Henschen A, Kehl M, Deutsch E.
    Hoppe Seylers Z Physiol Chem; 1983 Dec 28; 364(12):1747-51. PubMed ID: 6667926
    [Abstract] [Full Text] [Related]

  • 17. [Fibrinogen Bern II: hereditary fibrinogen variant with amino acid substitution of arginine replaced by histidine in position 16 of the A alpha chain].
    Rupp C, Sievi R, Furlan M, Beck EA.
    Schweiz Med Wochenschr; 1983 Oct 08; 113(40):1460-2. PubMed ID: 6648427
    [Abstract] [Full Text] [Related]

  • 18. A thrombin assay based upon the release of fibrinopeptide A from fibrinogen: definition of a new thrombin unit.
    Lewis SD, Shafer JA.
    Thromb Res; 1984 Jul 15; 35(2):111-20. PubMed ID: 6474412
    [Abstract] [Full Text] [Related]

  • 19. Fibrinogen Milano IV, another case of congenital dysfibrinogenemia with an abnormal fibrinopeptide A release (A alpha 16 Arg----His).
    Bögli C, Hofer A, Baudo F, Redaelli R, Furlan M.
    Haemostasis; 1992 Jul 15; 22(1):7-11. PubMed ID: 1521828
    [Abstract] [Full Text] [Related]

  • 20. Kinetic aspects of release of fibrinopeptides AP and AY by human alpha-thrombin.
    De Cristofaro R, Castagnola M.
    Haemostasis; 1991 Jul 15; 21(2):85-90. PubMed ID: 1959802
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.